MedTrace Logo

Intestinal Microflora in Lung Cancer After Chemotherapy

NCT02771470 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2017-05-23

No results posted yet for this study

Summary

Probiotics modulate the gut microflora and immune status in lung cancer who need chemotherapy.

Conditions

  • Lung Cancer
  • Effects of Chemotherapy
  • Tumor Immunity
  • Malnutrition

Interventions

DRUG

Probiotics

Microbial composition using probiotic

DRUG

placebo

Microbiota modulation using placebo

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • Yanqing Li, MD.PhD. · Qilu Hospital, Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02771470 on ClinicalTrials.gov